Clinuvel Pharmaceuticals Limited (CUV.AX)
Company Info
Highlights
A$570.69M
A$0.70
16.29
A$55.38M
A$50.09M
A$34.85M
A$11.04 - A$17.65
A$28.23
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of A$10,000 in Clinuvel Pharmaceuticals Limited, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Clinuvel Pharmaceuticals Limited had a return of -6.22% year-to-date (YTD) and -28.04% in the last 12 months. Over the past 10 years, Clinuvel Pharmaceuticals Limited had an annualized return of 12.15%, outperforming the S&P 500 benchmark which had an annualized return of 11.26%.
CUV.AX
-6.22%
-4.80%
-19.24%
-28.04%
-14.73%
12.15%
^GSPC (Benchmark)
3.96%
1.97%
9.03%
22.16%
12.60%
11.26%
Monthly Returns
The table below presents the monthly returns of CUV.AX, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 0.33% | -6.22% | |||||||||||
| 2024 | -1.87% | -12.87% | 4.97% | 4.81% | 5.65% | -3.33% | -2.73% | 4.95% | -10.35% | 1.28% | -7.39% | -8.29% | -24.38% |
| 2023 | 16.15% | -24.16% | 1.21% | 4.66% | -7.52% | -4.38% | 2.63% | 4.63% | -23.17% | -0.14% | 20.49% | -9.60% | -25.96% |
| 2022 | -15.40% | -12.38% | -8.48% | -10.29% | -4.05% | -6.54% | 26.40% | 7.46% | -7.70% | 5.27% | 0.20% | 10.56% | -20.20% |
| 2021 | -2.06% | 2.52% | 20.79% | 7.43% | 0.03% | 5.53% | -9.25% | 35.61% | 13.52% | -9.92% | -25.49% | -5.42% | 21.99% |
| 2020 | -2.64% | -35.85% | 7.54% | 15.28% | 9.94% | 5.90% | -14.07% | -5.67% | 12.26% | -11.37% | -2.08% | 10.33% | -21.45% |
| 2019 | 19.23% | 23.86% | -8.38% | -2.41% | 44.31% | -2.35% | -3.47% | -16.73% | -8.67% | 23.72% | -8.05% | 1.25% | 57.33% |
| 2018 | 8.67% | -1.91% | 13.40% | 18.69% | 3.40% | -9.38% | 12.17% | 19.51% | 49.42% | -27.37% | 6.25% | 6.47% | 121.24% |
| 2017 | 7.92% | -16.29% | 2.08% | -1.02% | 0.29% | 2.35% | -7.88% | 13.06% | -7.43% | 3.86% | 15.17% | 1.74% | 9.93% |
| 2016 | 12.16% | 25.43% | 13.51% | 3.57% | 8.05% | -8.08% | 16.20% | 4.58% | 15.43% | 39.44% | -4.73% | -7.45% | 183.26% |
| 2015 | -10.71% | -9.33% | -11.77% | -6.67% | 7.86% | -5.96% | -1.41% | 3.93% | -4.47% | 2.52% | -1.75% | -6.07% | -37.38% |
| 2014 | 48.96% | 6.01% | 4.66% | -7.01% | 6.17% | 9.68% | 26.47% | 27.91% | 19.64% | 13.98% | 15.20% | -2.78% | 342.13% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of CUV.AX is 11, meaning it’s performing worse than 89% of other stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Clinuvel Pharmaceuticals Limited (CUV.AX) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Clinuvel Pharmaceuticals Limited provided a 0.44% dividend yield over the last twelve months, with an annual payout of A$0.05 per share. The company has been increasing its dividends for 6 consecutive years.
| Period | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Dividend | A$0.05 | A$0.05 | A$0.05 | A$0.04 | A$0.03 | A$0.03 | A$0.03 | A$0.02 |
Dividend yield | 0.44% | 0.41% | 0.31% | 0.18% | 0.09% | 0.11% | 0.09% | 0.11% |
Monthly Dividends
The table displays the monthly dividend distributions for Clinuvel Pharmaceuticals Limited. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | A$0.00 | A$0.00 | A$0.00 | ||||||||||
| 2024 | A$0.00 | A$0.00 | A$0.00 | A$0.00 | A$0.00 | A$0.00 | A$0.00 | A$0.00 | A$0.05 | A$0.00 | A$0.00 | A$0.00 | A$0.05 |
| 2023 | A$0.00 | A$0.00 | A$0.00 | A$0.00 | A$0.00 | A$0.00 | A$0.00 | A$0.00 | A$0.05 | A$0.00 | A$0.00 | A$0.00 | A$0.05 |
| 2022 | A$0.00 | A$0.00 | A$0.00 | A$0.00 | A$0.00 | A$0.00 | A$0.00 | A$0.00 | A$0.04 | A$0.00 | A$0.00 | A$0.00 | A$0.04 |
| 2021 | A$0.00 | A$0.00 | A$0.00 | A$0.00 | A$0.00 | A$0.00 | A$0.00 | A$0.00 | A$0.03 | A$0.00 | A$0.00 | A$0.00 | A$0.03 |
| 2020 | A$0.00 | A$0.00 | A$0.00 | A$0.00 | A$0.00 | A$0.00 | A$0.00 | A$0.00 | A$0.03 | A$0.00 | A$0.00 | A$0.00 | A$0.03 |
| 2019 | A$0.00 | A$0.00 | A$0.00 | A$0.00 | A$0.00 | A$0.00 | A$0.00 | A$0.00 | A$0.03 | A$0.00 | A$0.00 | A$0.00 | A$0.03 |
| 2018 | A$0.02 | A$0.00 | A$0.00 | A$0.00 | A$0.02 |
Dividend Yield & Payout
Dividend Yield
Payout Ratio
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the Clinuvel Pharmaceuticals Limited. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Clinuvel Pharmaceuticals Limited was 92.52%, occurring on Dec 30, 2013. Recovery took 1100 trading sessions.
The current Clinuvel Pharmaceuticals Limited drawdown is 74.61%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -92.52% | Apr 16, 2007 | 1700 | Dec 30, 2013 | 1100 | May 7, 2018 | 2800 |
| -74.93% | Oct 10, 2019 | 1331 | Jan 13, 2025 | — | — | — |
| -74.55% | Nov 19, 2004 | 300 | Jan 25, 2006 | 289 | Mar 19, 2007 | 589 |
| -70% | Feb 16, 2001 | 158 | Sep 25, 2001 | 36 | Nov 14, 2001 | 194 |
| -66.1% | Jan 3, 2002 | 123 | Jun 24, 2002 | 255 | Jun 16, 2003 | 378 |
Volatility
Volatility Chart
The current Clinuvel Pharmaceuticals Limited volatility is 7.77%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Valuation
The Valuation section provides an assessment of the market value of Clinuvel Pharmaceuticals Limited compared to its peers in the Biotechnology industry.
PE Ratio
The chart displays the price to earnings (P/E) ratio for CUV.AX in comparison to other companies of the Biotechnology industry. Currently, CUV.AX has a PE value of 16.3. This PE ratio falls in the average range for the industry.PEG Ratio
The chart displays the price to earnings to growth (PEG) ratio for CUV.AX in comparison to other companies of the Biotechnology industry. Currently, CUV.AX has a PEG value of 0.0. This PEG ratio is much higher than those of other companies of the industry. This might be an indicator of the company being overvalued.Historical P/E Ratio Chart
The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Clinuvel Pharmaceuticals Limited.
Loading data...
Income Statement
| TTM | |
|---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |